- Scheme Category:
- Equity Scheme >
- Sectoral/Thematic Funds
NAV: ₹ 497.4087 ↑ 0.34%
[as on 15 October, 2025]
NAV chart with SMA (Simple moving average) overlay
SMA (Simple Moving Average)
Returns
Name | YTD | 1D | 1W | 1M | 3M | 1Y | 3Y | 5Y | 7Y | 10Y |
---|
SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH | -0.27% | 0.34% | 1.28% | -0.18% | -1.25% | 3.06% | 26.83% | 20.78% | 20.99% | 12.19% |
Portfolio
Asset allocation
Equity | Debt | Realestate | Commodities | Cash & Equivalents |
---|
96.36% |
0.08% (Arbitrage: 0.00%) |
0.00% |
0.00% |
3.56% |
Equity
Name | Sector | Weight % |
---|
Sun Pharmaceutical Industries Ltd. | Pharmaceuticals & Biotechnology | 10.94% |
Divi's Laboratories Ltd. | Pharmaceuticals & Biotechnology | 6.36% |
Max Healthcare Institute Ltd. | Healthcare Services | 5.67% |
Cipla Ltd. | Pharmaceuticals & Biotechnology | 4.59% |
Lupin Ltd. | Pharmaceuticals & Biotechnology | 4.08% |
Fortis Healthcare Ltd. | Healthcare Services | 3.70% |
Torrent Pharmaceuticals Ltd. | Pharmaceuticals & Biotechnology | 3.66% |
Gland Pharma Ltd. | Pharmaceuticals & Biotechnology | 3.54% |
Mankind Pharma Ltd. | Pharmaceuticals & Biotechnology | 3.34% |
Aster DM Healthcare Ltd. | Healthcare Services | 3.22% |
Jupiter Life Line Hospitals Ltd. | Healthcare Services | 3.20% |
Krishna Institute of Medical Sciences Ltd. | Healthcare Services | 3.12% |
Concord Biotech Ltd. | Pharmaceuticals & Biotechnology | 3.02% |
Acutaas Chemicals Ltd. | Pharmaceuticals & Biotechnology | 3.02% |
Laurus Labs Ltd. | Pharmaceuticals & Biotechnology | 3.00% |
Abbott India Ltd. | Pharmaceuticals & Biotechnology | 2.98% |
Polymedicure Ltd. | Healthcare Equipment & Supplies | 2.97% |
Biocon Ltd. | Pharmaceuticals & Biotechnology | 2.77% |
Alkem Laboratories Ltd. | Pharmaceuticals & Biotechnology | 2.76% |
Cohance Lifesciences Ltd. | Pharmaceuticals & Biotechnology | 2.68% |
Aether Industries Ltd. | Chemicals & Petrochemicals | 2.68% |
Anthem Biosciences Ltd. | Pharmaceuticals & Biotechnology | 2.32% |
Aurobindo Pharma Ltd. | Pharmaceuticals & Biotechnology | 1.93% |
Vijaya Diagnostic Centre Ltd. | Healthcare Services | 1.53% |
Pfizer Ltd. | Pharmaceuticals & Biotechnology | 1.28% |
Rainbow Children's Medicare Ltd. | Healthcare Services | 1.27% |
Gufic Biosciences Ltd. | Pharmaceuticals & Biotechnology | 0.90% |
Sanofi Consumer Healthcare India Ltd. | Pharmaceuticals & Biotechnology | 0.90% |
Medplus Health Services Ltd. | Retailing | 0.87% |
Lonza Group | Pharmaceuticals & Biotechnology | 4.06% |
Debt
Name | Rating | Weight % |
---|
182 DAY T-BILL 20.11.25 | Sovereign | 0.08% |
Portfolio data is as on date 30 September, 2025
NAV (Net asset value) history
SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH - 30 days NAV history
Date | NAV |
---|
15 October, 2025 | 497.4087 |
14 October, 2025 | 495.7478 |
13 October, 2025 | 498.1684 |
10 October, 2025 | 497.3678 |
9 October, 2025 | 493.6039 |
8 October, 2025 | 491.0996 |
7 October, 2025 | 490.3968 |
6 October, 2025 | 490.6772 |
3 October, 2025 | 485.8890 |
1 October, 2025 | 486.3971 |
30 September, 2025 | 482.1081 |
29 September, 2025 | 481.2061 |
26 September, 2025 | 481.4801 |
25 September, 2025 | 490.9605 |
24 September, 2025 | 493.7170 |
23 September, 2025 | 496.5753 |
22 September, 2025 | 498.7166 |
19 September, 2025 | 502.8809 |
18 September, 2025 | 501.8904 |
17 September, 2025 | 497.5048 |
16 September, 2025 | 498.4142 |
15 September, 2025 | 498.3237 |
12 September, 2025 | 499.8290 |
11 September, 2025 | 499.0596 |
10 September, 2025 | 497.5214 |
9 September, 2025 | 496.7407 |
8 September, 2025 | 494.8270 |
5 September, 2025 | 496.0496 |
4 September, 2025 | 495.9138 |
3 September, 2025 | 495.7526 |
FAQ (Frequently asked questions)
What is latest/current NAV/price of SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH?
The latest NAV of SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH is 497.4087 as on 15 October, 2025.
What are YTD (year to date) returns of SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH?
The YTD (year to date) returns of SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH are -0.27% as on 15 October, 2025.
What are 1 year returns of SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH?
The 1 year returns of SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH are 3.06% as on 15 October, 2025.
What are 3 year CAGR returns of SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH?
The 3 year annualized returns (CAGR) of SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH are 26.83% as on 15 October, 2025.
What are 5 year CAGR returns of SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH?
The 5 year annualized returns (CAGR) of SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH are 20.78% as on 15 October, 2025.
What are 10 year CAGR returns of SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH?
The 10 year annualized returns (CAGR) of SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH are 20.78% as on 15 October, 2025.